Data / Form D filings / Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp: Form D filings
Adaptive Biotechnologies Corp, a biotechnology company in Seattle, WA, filed 9 Form D notices with the SEC between 2009 and 2015. The latest, on May 11, 2015, reports $195.1 million sold of a $195.1 million offering to 16 investors.
Find out what Adaptive Biotechnologies Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1551 EASTLAKE AVENUE EAST SUITE 200, Seattle, WA, 98102
- Phone
- (206) 659-0067
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Washington
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1478320
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2015 | New notice | $195,099,954 | $195,099,954 | $0 | 16 | May 5, 2015 | sec.gov |
| Jan 22, 2015 | New notice | $93,750,000 | $93,750,000 | $0 | 4 | Jan 7, 2015 | sec.gov |
| Jan 21, 2015 | New notice | $95,716,444 | $95,716,444 | $0 | 61 | Jan 7, 2015 | sec.gov |
| Aug 4, 2014 | Amendment | $106,999,480 | $106,999,480 | $0 | 6 | Apr 4, 2014 | sec.gov |
| Apr 15, 2014 | New notice | $104,999,480 | $104,999,480 | $0 | 4 | Apr 4, 2014 | sec.gov |
| Jul 12, 2013 | New notice | $19,999,997 | $5,024,792 | $14,975,205 | 3 | Jul 1, 2013 | sec.gov |
| Jun 21, 2012 | New notice | $5,048,707 | $2,649,272 | $2,399,435 | 37 | Jun 7, 2012 | sec.gov |
| Jun 2, 2011 | New notice | $7,500,000 | $5,821,524 | $1,678,476 | 63 | May 20, 2011 | sec.gov |
| Dec 28, 2009 | New notice | $5,000,000 | $3,955,000 | $1,045,000 | 50 | Dec 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Neupert | Director | |
| Andris Zoltners | Director | |
| Tom Willis | Director | |
| Kathleen Determann | Executive Officer | |
| Chad Robins | Executive Officer, Director | |
| Rob Hershberg | Director | |
| Dean Schorno | Executive Officer | |
| John Stuelpnagel | Director | |
| Rob Rosen | Director | |
| Chad Cohen | Director | |
| Arnold Levine | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of May 11, 2015 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Adaptive Biotechnologies Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.